SecBot SecBot
8-K ·Filed Oct 22, 2026

KNSA

Kiniksa Pharmaceuticals International, plc
NEUTRAL
Impact 2/10
Horizondays Processed4d 19h ago SEC0001730430-26-000034
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Routine internal promotion with no change in strategic direction. Monitor next quarterly earnings for any operational updates under the new President and COO.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+1d ⚠ clustered
KNSA ▼ -4.89% at T+1d
NEUTRAL call -4.89% · α vs SPY -5.60% · entry $76.73 → $72.98
Next anchor: T+5d tomorrow
Entry = T+0 close
Oct 22, 2026
via day close
T+1d
-4.89%
call -4.89% · α -5.60%
$72.98
settled 4d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 23d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Kiniksa appointed Ross Moat as President and COO, effective immediately, with a base salary increase to $700,000 and target bonus to 60% from $650,000 and 55%, effective January 1, 2027. This is a routine internal promotion with no red flags — Mr. Moat has been with the company since 2019 and previously served as EVP, COO.

Key Facts

  • Ross Moat appointed President and COO effective October 17, 2026
  • Annual base salary increased to $700,000 from $650,000 effective January 1, 2027
  • Annual target bonus increased to 60% from 55% effective January 1, 2027
  • Mr. Moat continues to report to Chairman and CEO Sanj K. Patel
  • No family relationships or related party transactions disclosed

Financial Impact

Compensation increase of $50,000 base salary and 5% bonus target — immaterial relative to company financials

compensation

Risk Factors

  • No material risks identified from this filing

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001730430-26-000034
Document: 0001730430-26-000034-index-headers.html0001730430-26-000034
Document: 0001730430-26-000034-index.html0001730430-26-000034
Document: 0001730430-26-000034.txt0001730430-26-000034
16 reports for KNSA
Performance horizon
60% Hit rate @ T+60 3 of 5 directional calls Went positive at some point 5 of 5 best @ T+60▲ +17.08%Apr 28, 2026
Filters
Rows
Reports for KNSA — sortable, filterable
TypeNow
Oct 27, 2026
today
8-K
BULLISH ★ 6/10
$76.00awaiting T+60—$87.16 (+14.69%)
Oct 27, 2026
today
Press Release
BULLISH ★ 6/10
$75.00awaiting T+60—$87.16 (+16.21%)
Oct 22, 2026
4d ago
8-K
NEUTRAL ★ 2/10
$76.73awaiting T+60—$87.16 (+13.59%)
Oct 22, 2026
4d ago
Press Release
NEUTRAL ★ 1/10
$80.79awaiting T+60—$87.16 (+7.88%)
Sep 3, 2026
7w ago
144
NEUTRAL ★ 2/10
$77.91awaiting T+60—$87.16 (+11.87%)
Jul 28, 2026
13w ago
8-K
BULLISH ★ 7/10
$79.44 $79.70▲ +0.33%▼ −4.02%$87.16 (+9.72%)
Jul 28, 2026
13w ago
Press Release
BULLISH ★ 7/10
$79.44 $79.70▲ +0.33%▼ −4.02%$87.16 (+9.72%)
May 26, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$51.84 $78.47▲ +51.37%▲ +49.49%$87.16 (+68.13%)
May 1, 2026
25w ago
8-K
NEUTRAL ★ 2/10
$57.62 $80.92▲ +40.44%▲ +38.58%$87.16 (+51.27%)
Apr 28, 2026
25w ago
144
BEARISH ★ 6/10
$52.99 $62.84▼ −18.59%▼ −14.48%$87.16 (−64.48%)
Showing 10 of 16

US Market Status

Market Open — Closes in 4h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 22, 2026